This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignees: Kyowa Kirin Co., Ltd., Nippon Telegraph and Telephone Corporation. Active years: 2008-2024.
Location History:
- Choufu, JP (2009)
- Tokyo, JP (2008 - 2022)
- Chiyoda-ku, JP (2023 - 2024)
Company Filing History:
3 out of 46 
2 out of 5,300 
Years Active: 2008-2024
Title: Takashi Imaeda: Innovator in Anticancer Compounds
Introduction
Takashi Imaeda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer activity. With a total of five patents to his name, Imaeda's work is recognized for its potential impact on cancer treatment.
Latest Patents
Imaeda's latest patents focus on compounds that exhibit anticancer properties. One of his notable inventions is a compound having anticancer activity, or a pharmaceutically acceptable salt thereof. This compound is represented by a specific formula, where certain groups are selected from a defined set of formulas. The innovative nature of this compound lies in its potential effectiveness against cancer, showcasing Imaeda's commitment to advancing medical science.
Career Highlights
Throughout his career, Takashi Imaeda has worked with esteemed organizations such as Kyowa Kirin Co., Ltd. and Nippon Telegraph and Telephone Corporation. His experience in these companies has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Imaeda has collaborated with notable coworkers, including Kimitaka Endo and Jouji Nakayama. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
In summary, Takashi Imaeda is a distinguished inventor whose work in anticancer compounds has the potential to make a significant difference in cancer treatment. His patents and collaborations reflect his dedication to innovation in the pharmaceutical field.